TrialDrugs in R&D2020

Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome.

Michael Rosenbloom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.